Matches in Nanopublications for { ?s ?p "[Patients with ALK gene rearrangements (OR = 5.50; 95% CI = 1.76, 17.18; P = .003) and patients with EGFR mutations (OR = 5.17; 95% CI = 1.63, 16.43; P = .006) were predisposed to liver metastasis compared to the triple negative cohort.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[Patients with ALK gene rearrangements (OR = 5.50; 95% CI = 1.76, 17.18; P = .003) and patients with EGFR mutations (OR = 5.17; 95% CI = 1.63, 16.43; P = .006) were predisposed to liver metastasis compared to the triple negative cohort.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Patients with ALK gene rearrangements (OR = 5.50; 95% CI = 1.76, 17.18; P = .003) and patients with EGFR mutations (OR = 5.17; 95% CI = 1.63, 16.43; P = .006) were predisposed to liver metastasis compared to the triple negative cohort.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP599273.RAJv6Pw3p1BNEzHKzb13EbYqwpqi4OdTMMIK66xR9oSjk130_assertion description "[Patients with ALK gene rearrangements (OR = 5.50; 95% CI = 1.76, 17.18; P = .003) and patients with EGFR mutations (OR = 5.17; 95% CI = 1.63, 16.43; P = .006) were predisposed to liver metastasis compared to the triple negative cohort.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP599273.RAJv6Pw3p1BNEzHKzb13EbYqwpqi4OdTMMIK66xR9oSjk130_provenance.
- NP651823.RAHkr-WipJDUzIX3xIGcmw4xdEcnXsSLRM_tpLqRtah4k130_assertion description "[Patients with ALK gene rearrangements (OR = 5.50; 95% CI = 1.76, 17.18; P = .003) and patients with EGFR mutations (OR = 5.17; 95% CI = 1.63, 16.43; P = .006) were predisposed to liver metastasis compared to the triple negative cohort.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651823.RAHkr-WipJDUzIX3xIGcmw4xdEcnXsSLRM_tpLqRtah4k130_provenance.
- NP235677.RAGYCPi-bXfTfOlzwN3TVb6Sj3L3p62aOI5XpOEgID3jc130_assertion description "[Patients with ALK gene rearrangements (OR = 5.50; 95% CI = 1.76, 17.18; P = .003) and patients with EGFR mutations (OR = 5.17; 95% CI = 1.63, 16.43; P = .006) were predisposed to liver metastasis compared to the triple negative cohort.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP235677.RAGYCPi-bXfTfOlzwN3TVb6Sj3L3p62aOI5XpOEgID3jc130_provenance.
- NP369848.RAOPcOghUvQv-4KJtBfKLGG-zaW9OyyoeQpiXpt6x5Vqs130_assertion description "[Patients with ALK gene rearrangements (OR = 5.50; 95% CI = 1.76, 17.18; P = .003) and patients with EGFR mutations (OR = 5.17; 95% CI = 1.63, 16.43; P = .006) were predisposed to liver metastasis compared to the triple negative cohort.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP369848.RAOPcOghUvQv-4KJtBfKLGG-zaW9OyyoeQpiXpt6x5Vqs130_provenance.
- NP956397.RAK4FNy0tPa_qt07LZo2HFI0MxxPct0kqgZb2hGbB5h6c130_assertion description "[Patients with ALK gene rearrangements (OR = 5.50; 95% CI = 1.76, 17.18; P = .003) and patients with EGFR mutations (OR = 5.17; 95% CI = 1.63, 16.43; P = .006) were predisposed to liver metastasis compared to the triple negative cohort.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP956397.RAK4FNy0tPa_qt07LZo2HFI0MxxPct0kqgZb2hGbB5h6c130_provenance.
- NP956395.RA7_ovYtiZupiBXwTqw84teguyT9GbeY6C1zOpEcUPOQg130_assertion description "[Patients with ALK gene rearrangements (OR = 5.50; 95% CI = 1.76, 17.18; P = .003) and patients with EGFR mutations (OR = 5.17; 95% CI = 1.63, 16.43; P = .006) were predisposed to liver metastasis compared to the triple negative cohort.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP956395.RA7_ovYtiZupiBXwTqw84teguyT9GbeY6C1zOpEcUPOQg130_provenance.